Noble Financial initiated coverage on shares of electroCore (NASDAQ:ECOR) in a report issued on Wednesday, Briefing.com Automated Import reports. The brokerage issued an outperform rating and a $19.00 price target on the stock.
Separately, Zacks Investment Research raised shares of electroCore from a sell rating to a hold rating in a report on Tuesday, April 9th. One analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and an average target price of $20.67.
Shares of NASDAQ:ECOR traded down $0.18 during mid-day trading on Wednesday, reaching $5.97. The company had a trading volume of 168,887 shares, compared to its average volume of 85,883. The stock has a market capitalization of $175.76 million and a PE ratio of -5.02. electroCore has a one year low of $4.16 and a one year high of $20.25.
In other electroCore news, insider Joseph P. Errico sold 10,408 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $6.97, for a total transaction of $72,543.76. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Joseph P. Errico sold 39,592 shares of the business’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of $5.52, for a total transaction of $218,547.84. The disclosure for this sale can be found here.
A number of hedge funds have recently modified their holdings of ECOR. New York State Common Retirement Fund bought a new stake in electroCore during the 4th quarter valued at $41,000. American International Group Inc. raised its holdings in electroCore by 95.3% during the 1st quarter. American International Group Inc. now owns 7,759 shares of the company’s stock valued at $54,000 after acquiring an additional 3,787 shares during the period. Wsfs Capital Management LLC bought a new stake in electroCore during the 4th quarter valued at $63,000. Rhumbline Advisers bought a new stake in electroCore during the 1st quarter valued at $73,000. Finally, Two Sigma Investments LP bought a new stake in electroCore during the 4th quarter valued at $85,000. 14.54% of the stock is currently owned by institutional investors and hedge funds.
electroCore Company Profile
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Read More: What is a bull market?
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.